IRF9 and systemic lupus erythematosus: We also observed that SLE patients with active disease (BILAG > 8) displayed an elevated IFN-I signature measured by the expression of MX1, MCL1, and IRF9, compared to patients with inactive disease (BILAG < 8) and healthy individuals (Figures 4A).